Castle Creek Arbitrage’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-233,177
Closed -$7.44K 231
2023
Q3
$7.44K Hold
233,177
﹤0.01% 197
2023
Q2
$9.93K Hold
233,177
﹤0.01% 274
2023
Q1
$9.21K Hold
233,177
﹤0.01% 357
2022
Q4
$18.2K Hold
233,177
﹤0.01% 334
2022
Q3
$51K Hold
233,177
﹤0.01% 438
2022
Q2
$64K Hold
233,177
﹤0.01% 431
2022
Q1
$282K Sell
233,177
-30,000
-11% -$29.2K 0.01% 399
2021
Q4
$453K Buy
+263,177
New +$447K 0.02% 393

Other funds holding HLGN.WS

Castle Creek Arbitrage's HLGN.WS Position: Q4 2023 in Review

Castle Creek Arbitrage sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q4 2023, closing a stake of 233,177 shares — an estimated $7.44K sold.

Castle Creek Arbitrage first reported a position in HLGN.WS in Q4 2021 and held it in 8 quarters. The position peaked at $453K in Q4 2021. 3 funds tracked by Wall St. Rank hold HLGN.WS as of Q4 2023.

  • Castle Creek Arbitrage reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q4 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 233,177 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q4 2023, an estimated $7.44K.
  • Castle Creek Arbitrage first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2021 and held it in 8 quarters.
  • Castle Creek Arbitrage's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $453K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q4 2023.

Based on Castle Creek Arbitrage's 13F filing for Q4 2023.